Kenneth C. Frazier - 24 Feb 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Executive Chair, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Kenneth C. Frazier
Issuer symbol
MRK
Transactions as of
24 Feb 2022
Transactions value $
$8,783,563
Form type
4
Filing time
28 Feb 2022, 15:15:08
Previous filing
04 Jan 2022
Next filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $8.78M +119K +20.36% $73.51 706K 24 Feb 2022 Direct F1, F2
holding MRK Common Stock - 401(k) Plan 4.38K 24 Feb 2022 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through January 7, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.